• 24 MAR 20
    • 0

    COVID-19: Guidance on clinical trials for institutions, HRECs, researchers and sponsors

    COVID-19: Guidance on clinical trials for institutions, HRECs, researchers and sponsors - Word 36 KB is a joint statement that reflects the shared views of all state and territory Departments of Health, the Therapeutic Goods Administration (TGA), National Health and Medical Research Council (NHMRC) and the Clinical Trials Project Reference Group (CTPRG), of which all of these entities are members.

    This guidance provides general information and advice to institutions conducting or overseeing research, Human Research Ethics Committees (HRECs), researchers and sponsors in the context of the COVID-19 pandemic. It is directed towards those involved in clinical trial research and other relevant clinical research, but also may be of use to institutions, HRECs and researchers in other fields.

    The advice represents current thinking and best practice at the government level and will be reviewed and updated regularly to reflect changes in government policy, public health advice and the needs of those conducting and participating in clinical research in Australia.

    Leave a reply →

Leave a reply

Cancel reply
Skip to toolbar